(Q45877251)

English

Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience

scientific article published on 20 February 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

0 references

0 references

tranexamic acid

1 reference

based on heuristic

inferred from title

author name string

M Holmström

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

H T T Tran

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

P A Holme

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

publication date

20 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

18

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

544-549

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

High dose factor VIIa improves clot structure and stability in a model of haemophilia B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Tranexamic acid: a review of its use in surgery and other indications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

The epidemiology of inhibitors in haemophilia A: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Total dental extraction in a patient with F VIII inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02748.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2012.02748.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22348384

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45877251&oldid=2233198568"